findmyKOL

Jose Santacruz, MD

Basic profile

Houston Methodist

ORCIDNPI
RegionHouston, TX · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jose Santacruz is a Respiratory physician affiliated with Houston Methodist. OpenAlex indexes 55 publications with 857 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
55publications

Distinct works indexed by OpenAlex, matched via ORCID.

857citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
20companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6560 Fannin St Ste 1632
Houston, TX 770302734

Telephone

713-255-4000

Provider last certified this registry record 2 Nov 2023.

View the NPPES registry record

Industry payments

20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    53.7%
    Corticosteroid34.4%
    Symbicort41%Breo Ellipta21%Trelegy Ellipta18%Budesonide-Formoterol Fumarate9%Breyna5%Fluticasone Propionate4%Asmanex Hfa4%
    Part D<11 patients
    beta2-Adrenergic Agonist16.3%
    Albuterol Sulfate Hfa100%
    Part D73 patients

    + 1 more class in this area

  • Anti-infectives

    16.9%
    Macrolide Antimicrobial5.6%
    Azithromycin100%
    Part D30 patients
    Fluoroquinolone Antibacterial3.7%
    Levofloxacin100%
    Part D23 patients

    + 4 more classes in this area

  • Dermatology

    15.5%
    Corticosteroid15.5%
    Triamcinolone acetonide64%Methylprednisolone36%
    Part D + Part B42 patients
Where care is delivered (Part B)48.7% facility · 51.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”